Übersicht

Eignung

Details zum Design

Arme & Interventionen

Ergebnismessungen

Studienzentren

Quelle: NCT06427954

Rekrutierung

THRIVE: Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer

Interventionsstudie

Phase nicht angegeben

Mass General Hospital

Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.

Detaillierte Beschreibung anzeigen

Behandlungskategorie

Verhalten

Erforderliche Mutationen

Keine

Studie gestartet

2024-08-06

Zuletzt vom Sponsor aktualisiert

2024-11-25

Voraussichtlicher Abschluss

2027-09-01

Eignung

Einschlusskriterien

* Adults (greater than or equal to 18 years)

* Diagnosed with advanced non-small cell lung cancer (NSCLC) that is not being treated with curative intent or extensive stage small cell lung cancer (SCLC) within the past 12 weeks.

* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) = 0-2 (i.e., fully active to at least ambulatory and up and about more than 50% of waking hours).

* Sufficient English proficiency to utilize THRIVE in English (Note: patients can complete outcome measures in Spanish if preferred).

* Significant uncontrolled psychiatric disorder (e.g., psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (e.g., dementia, cognitive impairment), which the treating oncology clinician reports would prohibit the ability to participate in study procedures.

Ausschlusskriterien

Glauben Sie, dass diese klinische Studie fälschlicherweise angezeigt wird?

Design-Details

ZuteilungRandomized

InterventionsmodellParallel Assignment

MaskierungSingle

Anzahl der Teilnehmer250

Arme & Interventionen

Arme

Interventionen

Typ: Active Comparator

Beschreibung: Patients assigned to the intervention will be provided a study-issued tablet computer from which they will access the THRIVE digital health app. Study staff will give intervention patients a comprehensive tutorial and detailed instructions regarding how to use the app. Tutorial sessions may be conducted in person during a clinic appointment, via telephone, and/or via Zoom videoconferencing. Participants will complete the intervention modules at their desired pace over approximately 10 weeks.

Interventionen:

Digital Health App

Ergebnismessungen

Primäre Ergebnismessungen

Functional Assessment of Cancer Therapy - Lung (FACT-L)12 weeks

Quality of Life (higher scores indicate better quality of life)

Sekundäre Ergebnismessungen

MD Anderson Symptom Inventory (MDASI)12 weeks

Physical Symptoms (higher scores indicate worse symptoms)

Hospital Anxiety and Depression Scale (HADS)12 weeks

Anxiety and Depression Symptoms (higher scores indicate worse symptoms)

Brief Cope (Modified)12 weeks

Coping (higher scores indicate greater use of coping strategy)

Cancer Self-Efficacy Scale12 weeks

Self-efficacy (higher scores indicate greater self-efficacy)

FACT-LOver 24 weeks

Quality of Life (higher scores indicate better quality of life)

MDASIOver 24 weeks

Physical Symptoms (higher scores indicate worse symptoms)

HADSOver 24 weeks

Anxiety and Depression Symptoms (higher scores indicate worse symptoms)

Interessiert an einer Teilnahme?

Erfahren Sie mehr über diese Studie und ob Sie für eine Teilnahme in Frage kommen.

Studie vormerken

Studie per E-Mail teilen

Studie herunterladen

Glauben Sie, dass diese klinische Studie fälschlicherweise angezeigt wird?

Studie melden

Studie herunterladen

Studienzentren

Diese Studie hat 3 Studienzentren

Mass General Hospital
Boston, Massachusetts, US

Rekrutierend

Boston, Massachusetts, 02114 US

Mass General Hospital

Rekrutierend

Los Angeles, California, 90024 US

University of California Los Angeles

Rekrutiert noch nicht

Los Angeles, California, 90073 US

Veteran Affairs Greater Los Angeles Health Care

Loading Maps...